Abstract

Spironolactone 5-mg/mL in Suspendit Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2018 - Volume 22, Number 2

Page(s): 152

Download in electronic PDF format for $75
  • Spironolactone 5-mg/mL in Suspendit Oral Suspension Page 1

Abstract

A formulation for preparing Spironolactone 5-mg/mL in Suspendit Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • spironolactone
  • potassium-sparing diuretic
  • antihypertensive agent
  • hypertension
  • high blood pressure
  • edema
  • liquid dosage form

Related Categories

  • DERMATOLOGY
  • FORMULATIONS
  • ALLERGY/IMMUNOLOGY/INFLAMMATION
  • CARDIOLOGY
  • UROLOGY/URINARY TRACT

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2018
Pg. 152
Spironolactone 5-mg/mL in Suspendit Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2017
Pg. 496
Spironolactone 5 mg/mL in SuspendIt Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 421
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jul/Aug 2017
Pg. 334-338
Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt
Author(s): Graves Richard, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
May/Jun 1997
Pg. 183
Spironolactone 5-mg/mL with Hydrochlorothiazide 5-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Sep/Oct 2018
Pg. 411
Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 43
Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2023
Pg. 326
Losartan Potassium 2.5-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2022
Pg. 516-521
Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage
Author(s): Kumaravelrajan Rajagopal, Karthik B, Venkatasan Suba
May/Jun 2007
Pg. 259-261
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents
Author(s): Gupta Vishnu D
May/Jun 2007
Pg. 248
Losartan Potassium 2.5-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jul/Aug 2008
Pg. 372-374
Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms
Author(s): Gupta Vishnu D
Nov/Dec 2018
Pg. 516-526
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Jul/Aug 2014
Pg. 326
Chlorothiazide 50-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2022
Pg. 342-351
Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt
Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
Jul/Aug 2024
Pg. 334-343
Physicochemical and Microbiological Stability of Compounded Clonidine Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt®
Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Johnson Jyra, Graves Richard A
Sep/Oct 2003
Pg. 386-388
Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared with the Use of Powder
Author(s): Gupta Vishnu D